Manuela Bergmann

senior scientist

German Institute of Human Nutrition
Country flagGermany

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (2)

Background: Current epidemiologic evidence indicates that smoking is associated with a lower endometrial cancer risk. However, it is unknown if this association is causal or confounded. To further elucidate the role of smoking in endometrial cancer risk, we conducted complementary observational and Mendelian randomization (MR) analyses. Methods: The observational analyses included 286,415 participants enrolled in the European Prospective Investigation into Cancer and Nutrition and 179,271 participants in the UK Biobank, and multivariable Cox proportional hazards models were used. In two-sample MR analyses, genetic variants robustly associated with lifetime amount of smoking ( n = 126 variants) and ever having smoked regularly ( n = 112 variants) were selected and their association with endometrial cancer risk (12,906 cancer/108,979 controls from the Endometrial Cancer Association Consortium) was examined. Results: In the observational analysis, lifetime amount of smoking and ever having smoked regularly were associated with a lower endometrial cancer risk. In the MR analysis accounting for body mass index, a genetic predisposition to a higher lifetime amount of smoking was not associated with endometrial cancer risk (OR per 1-SD increment: 1.15; 95% confidence interval: 0.91–1.44). Genetic predisposition to ever having smoked regularly was not associated with risk of endometrial cancer. Conclusions: Smoking was inversely associated with endometrial cancer in the observational analyses, although unsupported by the MR. Additional studies are required to better understand the possible confounders and mechanisms underlying the observed associations between smoking and endometrial cancer. Impact: The results from this analysis indicate that smoking is unlikely to be causally linked with endometrial cancer risk.

Year:

2025

Year:

2023

Collaborators (23)

Annika Idahl

Umea University

SWEDEN
View details

Marc Gunter

International Agency for Research on Cancer

FRANCE
View details

Ben Lacey

-

UNITED KINGDOM
View details

Naomi Allen

University of Oxford

UNITED KINGDOM
View details

Carlotta Sacerdote

Docenti di ruolo di Ia fascia

Università degli Studi del Piemonte Orientale Amedeo Avogadro

ITALY
View details

Anne Tjonneland

Professor

Københavns Universitet

DENMARK
View details

Christina Dahm

VIP, Professor

Aarhus University

DENMARK
View details

Tracy O'Mara

Team Head

QIMR Berghofer Medical Research Institute

AUSTRALIA
View details

Sophia Harlid

Umea University

SWEDEN
View details

Kim Overvad

Aarhus University

DENMARK
View details

Matthias B. Schulze

German Institute of Human Nutrition

GERMANY
View details

Inger Torhild Gram

Professor

UiT The Arctic University of Norway

NORWAY
View details

Ulrike Gisch

Professor

Justus Liebig University

GERMANY
View details

Tonje Braaten

Associate professor II

Nord University

NORWAY
View details

Alicia Heath

Imperial College London

UNITED KINGDOM
View details

Renée Fortner

Head of Division

Deutsches Krebsforschungszentrum

GERMANY
View details

Gianluca Severi

University of Firenze

ITALY
View details

Elom K Aglago

Imperial College London

UNITED KINGDOM
View details

Nicola Bondonno

Adjunct Lecturer

Edith Cowan University

AUSTRALIA
View details

Aurora Perez-Cornago

University of Oxford

UNITED KINGDOM
View details

Marina Kvaskoff

-

FRANCE
View details

Mattias Johansson

Scientist

International Agency for Research on Cancer

FRANCE
View details

Domenico PALLI

Head

Institute for Cancer Research, Prevention and Clinical Network-ISPRO

ITALY
View details